Meridian Investment Counsel Inc. lowered its stake in shares of SPDR S&P Biotech ETF ( NYSEARCA:XBI – Free Report ) by 1.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,242 shares of the exchange traded fund's stock after selling 200 shares during the quarter. Meridian Investment Counsel Inc.'s holdings in SPDR S&P Biotech ETF were worth $1,085,000 as of its most recent filing with the Securities and Exchange Commission.

https://www.dailypolitical.com/2023/08/04/spdr-sp-biotech-etf-nysearcaxbi-shares-sold-by-meridian-investment-counsel-inc.html

#dailypolitical